Baker Bros. Advisors’s Aligos Therapeutics ALGS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $599K | Hold |
|
|||||
|
2025
Q1 | $685K | Hold |
|
|||||
|
2024
Q4 | $3.31M | Hold |
|
|||||
|
2024
Q3 | $719K | Sell |
|
|||||
|
2024
Q2 | $727K | Hold |
|
|||||
|
2024
Q1 | $2.03M | Hold |
|
|||||
|
2023
Q4 | $1.38M | Hold |
|
|||||
|
2023
Q3 | $1.55M | Hold |
|
|||||
|
2023
Q2 | $2.02M | Hold |
|
|||||
|
2023
Q1 | $1.81M | Hold |
|
|||||
|
2022
Q4 | $1.98M | Hold |
|
|||||
|
2022
Q3 | $2.28M | Hold |
|
|||||
|
2022
Q2 | $2.51M | Hold |
|
|||||
|
2022
Q1 | $4.46M | Hold |
|
|||||
|
2021
Q4 | $24.6M | Hold |
|
|||||
|
2021
Q3 | $32.2M | Buy |
|
|||||
|
2021
Q2 | $32.8M | Hold |
|
|||||
|
2021
Q1 | $36.6M | Hold |
|
|||||
|
2020
Q4 | $44.5M | Buy |
|